AIM: The objective of this study was to determine the effects of lysophosphatidic acid (LPA) on endothelial functions and molecular alternations in both porcine coronary arteries and human coronary artery endothelial cells (HCAECs). METHODS AND RESULTS: The vessel rings and HCAECs were treated with clinically relevant concentrations of LPA for different times. Vasomotor reactivity was studied with a myograph tension system. LPA (10 and 50 μM) treatment for the vessel rings significantly reduced endothelium-dependent vasorelaxation in response to bradykinin (×10(-5)M) by 32% and 49%, respectively, compared with the control (P<0.05). LPA decreased endothelial nitric oxide synthase (eNOS) mRNA and immunoreactivity levels in the vessel rings. In HCAECs, LPA reduced eNOS mRNA, phospho-eNOS and total eNOS protein levels. In addition, superoxide anion levels in LPA-treated vessel rings and HCAECs were significantly increased by lucegenin-enhanced chemiluminescence assay and dihydroethidium staining, respectively. Mitochondrial membrane potential and ATP content in LPA-treated HCAECs were substantially decreased. The mRNA levels of reactive oxygen species generating enzymes NOX4 and p40(phox) were increased, while endogenous antioxidant enzyme superoxide dismutase 1 was decreased in response to LPA treatment in HCAECs. Furthermore, exogenous antioxidant molecule selenomethionine (SeMet) effectively reversed these LPA-induced effects in both porcine coronary arteries and HCAECs. CONCLUSIONS: LPA causes endothelial dysfunction by a mechanism associated with decreased eNOS expression and increased oxidative stress in porcine coronary arteries and HCAECs.
AIM: The objective of this study was to determine the effects of lysophosphatidic acid (LPA) on endothelial functions and molecular alternations in both porcine coronary arteries and human coronary artery endothelial cells (HCAECs). METHODS AND RESULTS: The vessel rings and HCAECs were treated with clinically relevant concentrations of LPA for different times. Vasomotor reactivity was studied with a myograph tension system. LPA (10 and 50 μM) treatment for the vessel rings significantly reduced endothelium-dependent vasorelaxation in response to bradykinin (×10(-5)M) by 32% and 49%, respectively, compared with the control (P<0.05). LPA decreased endothelial nitric oxide synthase (eNOS) mRNA and immunoreactivity levels in the vessel rings. In HCAECs, LPA reduced eNOS mRNA, phospho-eNOS and total eNOS protein levels. In addition, superoxide anion levels in LPA-treated vessel rings and HCAECs were significantly increased by lucegenin-enhanced chemiluminescence assay and dihydroethidium staining, respectively. Mitochondrial membrane potential and ATP content in LPA-treated HCAECs were substantially decreased. The mRNA levels of reactive oxygen species generating enzymes NOX4 and p40(phox) were increased, while endogenous antioxidant enzyme superoxide dismutase 1 was decreased in response to LPA treatment in HCAECs. Furthermore, exogenous antioxidant molecule selenomethionine (SeMet) effectively reversed these LPA-induced effects in both porcine coronary arteries and HCAECs. CONCLUSIONS:LPA causes endothelial dysfunction by a mechanism associated with decreased eNOS expression and increased oxidative stress in porcine coronary arteries and HCAECs.
Authors: W Siess; K J Zangl; M Essler; M Bauer; R Brandl; C Corrinth; R Bittman; G Tigyi; M Aepfelbacher Journal: Proc Natl Acad Sci U S A Date: 1999-06-08 Impact factor: 11.205
Authors: Mohamad Navab; Arnab Chattopadhyay; Greg Hough; David Meriwether; Spencer I Fogelman; Alan C Wagner; Victor Grijalva; Feng Su; G M Anantharamaiah; Lin H Hwang; Kym F Faull; Srinivasa T Reddy; Alan M Fogelman Journal: J Lipid Res Date: 2015-02-02 Impact factor: 5.922
Authors: Dawid S Chabowski; Andrew O Kadlec; Karima Ait-Aissa; Joseph C Hockenberry; Paul J Pearson; Andreas M Beyer; David D Gutterman Journal: Br J Pharmacol Date: 2018-10-11 Impact factor: 8.739
Authors: José Pablo Vázquez-Medina; Chandra Dodia; Liwei Weng; Clementina Mesaros; Ian A Blair; Sheldon I Feinstein; Shampa Chatterjee; Aron B Fisher Journal: FASEB J Date: 2016-05-13 Impact factor: 5.191
Authors: Ying Shao; Gayani Nanayakkara; Jiali Cheng; Ramon Cueto; William Y Yang; Joon-Young Park; Hong Wang; Xiaofeng Yang Journal: Antioxid Redox Signal Date: 2017-04-26 Impact factor: 8.401
Authors: Ewa D Micewicz; Omar S O Bahattab; Gary B Willars; Alan J Waring; Mohamad Navab; Julian P Whitelegge; William H McBride; Piotr Ruchala Journal: Eur J Med Chem Date: 2015-07-14 Impact factor: 6.514
Authors: Mohamad Navab; Greg Hough; Georgette M Buga; Feng Su; Alan C Wagner; David Meriwether; Arnab Chattopadhyay; Feng Gao; Victor Grijalva; Janet S Danciger; Brian J Van Lenten; Elin Org; Aldons J Lusis; Calvin Pan; G M Anantharamaiah; Robin Farias-Eisner; Susan S Smyth; Srinivasa T Reddy; Alan M Fogelman Journal: J Lipid Res Date: 2013-10-01 Impact factor: 5.922
Authors: Éva Ruisanchez; Péter Dancs; Margit Kerék; Tamás Németh; Bernadett Faragó; Andrea Balogh; Renukadevi Patil; Brett L Jennings; Károly Liliom; Kafait U Malik; Alan V Smrcka; Gabor Tigyi; Zoltán Benyó Journal: FASEB J Date: 2013-11-18 Impact factor: 5.191
Authors: Sara A Knowlden; Tara Capece; Milan Popovic; Timothy J Chapman; Fariba Rezaee; Minsoo Kim; Steve N Georas Journal: PLoS One Date: 2014-07-08 Impact factor: 3.240